Clinical trial
Intranasal Insulin Treatment in Patients With Schizophrenia
NCT00575666 is registered in ClinicalTrials.gov with University of Massachusetts, Worcester as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intranasal Insulin Treatment in Patients With Schizophrenia
- Lead sponsor
- University of Massachusetts, Worcester
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2007
- Completion date
- September 30, 2010
- Enrollment
- 45 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.